Completed PHASE2 INTERVENTIONAL 2-arm NCT01509079

Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

Phase 2 Study Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

Sponsor: HealthPartners Institute

Interventions Vitamin D3

Updated 8 times since 2017 Last updated: May 28, 2019 Started: Mar 31, 2012 Primary completion: Oct 31, 2014 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Joint Pain and Muscle Pain, this trial is completed. The trial is conducted by HealthPartners Institute and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Nov 2019 — Jan 2021 [monthly]

Completed PHASE2
Jul 2019 — Nov 2019 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jul 2019 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HealthPartners Institute
University of Minnesota
University of Southern California

Data source: HealthPartners Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States